Cargando…
The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors
Bleeding and thrombosis frequently occur in pediatric patients with extracorporeal membrane oxygenation (ECMO) therapy. Until now, most patients are anticoagulated with unfractionated heparin (UFH). However, heparin has many disadvantages, such as binding to other plasma proteins and endothelial cel...
Autores principales: | Neunert, Cindy, Chitlur, Meera, van Ommen, Cornelia Heleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299072/ https://www.ncbi.nlm.nih.gov/pubmed/35872781 http://dx.doi.org/10.3389/fmed.2022.887199 |
Ejemplares similares
-
Neonatal ECMO
por: Van Ommen, Cornelia Heleen, et al.
Publicado: (2018) -
Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation
por: Burstein, Barry, et al.
Publicado: (2019) -
Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017) -
Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients
por: Cho, Hwa Jin, et al.
Publicado: (2017) -
Context-Responsive Anticoagulation Reduces Complications in Pediatric Extracorporeal Membrane Oxygenation
por: Lin, John C., et al.
Publicado: (2021)